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Background: Recent analyses show that donor funding for child health is increasing, but little information is
available on actual costs to deliver child health care services. Understanding how unit costs scale with service
volume in Malawi can help planners allocate budgets as health services expand.
Methods: Data on facility level inputs and outputs were collected at 24 health centres in four districts of Malawi
visiting a random sample of government and a convenience sample of Christian Health Association of Malawi
(CHAM) health centres. In the cost function, total outputs, quality, facility ownership, average salaries and case mix
are used to predict total cost. Regression analysis identifies marginal cost as the coefficient relating cost to service
volume intensity.
Results: The marginal cost per patient seen for all health centres surveyed was US$ 0.82 per additional patient visit.
Average cost was US$ 7.16 (95% CI: 5.24 to 9.08) at government facilities and US$ 10.36 (95% CI: 4.92 to 15.80) at
CHAM facilities per child seen for any service. The first-line anti-malarial drug accounted for over 30% of costs, on
average, at government health centres. Donors directly financed 40% and 21% of costs at government and CHAM
health centres, respectively. The regression models indicate higher total costs are associated with a greater number
of outpatient visits but that many health centres are not providing services at optimal volume given their inputs.
They also indicate that CHAM facilities have higher costs than government facilities for similar levels of utilization.
Conclusions: We conclude by discussing ways in which efficiency may be improved at health centres. The first
option, increasing the total number of patients seen, appears difficult given existing high levels of child utilization;
increasing the volume of adult patients may help spread fixed and semi-fixed costs. A second option, improving
the quality of services, also presents difficulties but could also usefully improve performance.
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Recent data indicate uneven progress in reaching the
fourth Millennium Development Goal to reduce mortal-
ity in children under five (U5s) by two-thirds [1]. Al-
though recent analyses have shown that donor funding
for child health is increasing [2], little information is
available on what countries themselves pay for child
health [3], and thus data are lacking on the total amount
of resources devoted to child health. Lacking these data,
recent estimates of resource needs for child health rely
on modelling current resources based on coverage rates* Correspondence: bjohns@jhsph.edu
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reproduction in any medium, provided the orand treatment protocols, or simply modelling the total
costs needed if interventions were delivered at optimal
quality [4-8]. Estimates of the amount of resources de-
voted to child health are important both for analyses of
current resource allocations, such as national health ac-
counts or sub-accounts, and for estimates of resources
needed to achieve mortality reduction goals.
Recently, countries, including Malawi, have adopted
and are scaling up community-based case management
of childhood diseases [9], which is intended to address
some of the shortcomings of previous implementation de-
signs by moving care closer to households [10]. In Malawi,
health surveillance assistants perform community-based
case management outside of health facilities. However,
data on the costs of this new pathway are limited [11], andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing [12]. Data on costs of child health services and the
determinants of those costs are an important compo-
nent of assessing the cost-effectiveness of community-
based case management [10,12,13]. This study does not
assess questions related to community-based case man-
agement, but serves as a baseline for further data collec-
tion and analysis.
Analysis of the costs of health interventions ideally
would include the marginal costs of expanding services,
coupled with factors affecting costs, such as quality, case
mix, and scale [14]. In this paper, we examine the costs
of delivering child health services in 4 districts of Malawi
at the start of the community-based case management
programme for U5s. This analysis will help policymakers
understand the cost structure of child health services
and will provide a baseline for determining how costs
change over time and as the new programme expands.
Methods
The cost function specification and results refer to the
costs and outputs specific to child health services. We
use the terms total, average, marginal cost and other
terms throughout this paper to refer to the total, aver-
age, or marginal costs for child health services.
Setting
Malawi’s health budget operates using a sector-wide ap-
proach (SWAp), where government and donor funds are
pooled and distributed to districts9. Districts have broad
control over budgets in Malawi’s decentralized health
system. In principle, the catchment population of health
facilities determines budgets, but funding levels may dif-
fer by district. In practice, health facilities order drugs
from the central medical stores and thus costs are re-
sponsive to utilization. In addition to government health
facilities, the Christian Hospital Association of Malawi
(CHAM) operates health centres, which charge clients
for services, in coordination and cooperation with the
government.
Some donors operate, purchase, or distribute commod-
ities outside the SWAp; for example, The Global Fund to
Fight AIDS, Tuberculosis, and Malaria (GFATM) provides
funds to purchase anti-malarial drugs, The Global Alliance
for Vaccines and Immunisation (GAVI) purchases penta-
valent vaccines, and some donors may supply famine re-
lief, outbreak control, and other measures.
Data collection
We collected data in four districts, all from central or
southern Malawi, purposively selected in consultation
with Ministry of Health staff. Retrospective data collec-
tion for the fiscal year 2009/10 took place in November
2010 and February 2011. Within each district, we visitedfour government and two CHAM health centres. We
randomly selected government facilities, while we pur-
posively selected the mission health centres for conve-
nience of data collection; they are located nearest to
selected government health centres. At each facility,
quantities of resources used were recorded. Data were
collected on outputs of services, including number of
visits, vaccinations, etc. This included visits for diagnosis
of major disease categories (malaria, respiratory infec-
tion, diarrhoea, skin conditions, and malnutrition). We
collected summary data if available; otherwise we
extracted output data from facility records. Data on util-
ities and maintenance were collected either at the facility
(for mission health centres) or at the district health of-
fice (for government health centres). Prices were col-
lected from national suppliers or local retailers as
appropriate. All prices reflect the fiscal year 2009/10,
and were inflated, if needed, to and presented in 2010
US dollars, using an exchange rate of 151.75 [15]. We
annualized the costs of capital items using a 3% discount
rate [16].
We attempted to randomly sample 50 patient records
each for outpatient and inpatient, if applicable, child
under 5 visits at each facility. Without good data on the
expected mean, variance, or difference in the cost of
drugs between facilities, we did not perform sample size
calculations. We extracted data related to age, sex, diag-
nosis, and the amount and type of drugs prescribed.
Thirty-two per cent of sampled records were missing
some data and we imputed missing data using multiple
imputation by chained equations [17] and, in less than
1% of cases, standard treatment guidelines when this
method failed. The fraction of missing information was
less than 0.05 for 22 of the 24 facilities, and below 0.10
for the 2 remaining facilities; these patients were marked
with dummy variables to assess whether they were out-
liers. Results reflect uncertainty due to imputation.
We used data from pharmacy records to estimate the
quantities of drugs used only by children, namely the
paediatric formulations of Lumefantrine/Arthemether
(LA), all drugs in suspension, and vaccines. We used pa-
tient records to estimate the quantities for other drugs
due to the uncertainty in allocating these drugs to U5s.
Patient records were used to estimate less than 25% of
total drug costs. Direct allocation [18] of other re-
sources to children was based on staff interviews, time
motion studies, and room usage within a facility. We
did time motion studies for two hours in the morning
and two hours in the afternoon targeting at least one
provider per facility, with data collection staff observing
providers from outside the consultation room. Time the
provider spent during a child visit, time spent with
other patients, and time spent doing other tasks were
recorded.
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based on the primary target of the training or use of ve-
hicle; when this information is lacking, costs were allo-
cated based on the proportion of visits from children to
the total number of visits. Table 1 summarizes the data
collected. Costs related to HIV/AIDS, dental care, and
tuberculosis were excluded, either because they were
separate programs from child health or they treated a
negligible number of children. We interviewed up to 10
caretakers of children exiting each facility visited to as-
certain their payments for accessing care and other ex-
perience with the visit, although these data are not
directly used in the analysis.
This study received approval from the Johns Hopkins
University Bloomberg School of Public Health Ethical
Review Committee and the National Health Research
Committee in the Government of Malawi Ministry of
Health. Oral informed consent was obtained from facil-
ity in-charges on the day of the visit, and all respondents
gave oral informed consent before being interviewed
and/or observed. The study was judged to have minimal
risk to participants.
Cost function specification
To analyse cost data, we regress the total costs of ser-
vices against average prices, quantities of outputs, quality
of services, type of facility, and case mix [19]. Each of
these is discussed below. We check model specifications
to determine if variables should be transformed using
natural logs or if higher order terms should be included.Table 1 Data collected
Parameter
Population 62
Estimated population Under 5 11
Number of Health Facilities
Number of health facilities sampled
% of health facilities sampled 2
Population served of sample 18
% of district population served by sample 3
Number of staff interviewed
Number of patient files sampled (of which for inpatient) 27
Number of facilities with beds
Average number of beds among facilities with patient-beds (range)
(2 t
Number of facilities with laboratory
Average number of clinical staff (range)
(5 t
*Numbers in boldface are averages across the four districts, otherwise numbers reflDue to a low number of observations, interaction terms
are not assessed. Sensitivity analysis is described and
summarized in Additional file 1.
We collected staff salaries by grade at the district level,
rather than by individual. However, different mixes of
the types of staff at facilities, coupled with between dis-
trict differences in salaries, mean that the average salary
for clinical staff is different at all facilities observed, ran-
ging from just under $2,200 to over $13,000. Thus, we
include this in the model as an indicator of input prices.
Separate measures of at least three outputs could be
included: the number of fully immunized children, the
number of outpatient visits by children, and the number
of inpatient admissions for children. Ideally, we would
include emergency services, numbers fed through famine
relief programs, and inpatient length of stay measures,
but these data are not available. Since all facilities visited
are first line health centres, we use outputs to measure
the size and scope of services offered.
Quality is harder to observe, and is enhanced by verifi-
cation of diagnosis and medication by an expert [20].
Lacking this data, we use data from patient records to
estimate ‘the number of children correctly medicated’,
which we define as the proportion of cases with a
recorded diagnosis of a certain disease for whom the
correct medication was also recorded as having been
prescribed. The number of diseases available for ana-
lysis is limited. Three diseases, malaria, diarrhoea, and
pneumonia/ARI, constitute over 60% of all cases and are
used as indicator conditions for quality measurement. WeDistrict Average / Total*
1 2 3 4
4,445 511,279 317,324 309,778 440,707
4,834 90,320 59,239 61,823 81,554
30 29 15 11 21
6 6 6 6 24
0% 21% 40% 55% 28%
6,666 162,763 128,507 129,326 607,262
0% 32% 40% 42% 36%
12 12 12 11 47
3 (0) 199 (0) 300 (0) 332 (32) 1104 (32)
6 6 5 5 22
4.0 5.2 7.2 6.4 5.5
o 10) (2 to 11) (2 to 12) (2 to 12)
0 0 2 1 3
5.2 3.7 3.5 4.5 4.2
o 12) (3 to 5) (2 to 6) (3 to 7)
ect total values.
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first or second line drugs were prescribed to children di-
agnosed with these diseases.
We use ownership to delineate facility type. Case mix
is assessed as the percentage of visits due to particular
diseases or severity of illnesses; we include the propor-
tion of outpatient visits diagnosed with malaria because
drugs for malaria are the most costly drug across facility
types.
After running regressions of the form:




we calculate the marginal cost as the expected change in
cost when producing one more of a given type of output.
Specifically marginal cost is calculated as:
dCost=dVolume ¼ β1 þ β2Volume; ð2Þ
where Volume is set to the mean across facilities. In
contrast, the average incremental cost is the change in
costs from going from zero to the facility-mean, esti-
mated by taking the difference between the predictions
of the regression when Volume is set to zero and set toTable 2 Summary of data used in analysis
Variable N
(all faci
Total costs (US$) 24
Outpatient visits for children U5 24
Inpatient admittances for children U5 24
Fully immunized children 24
Average salary of clinical staff (US$) 24
Proportion of drugs out of stock (average of beginning and end of
fiscal year)
24
Proportion of U5 outpatient visits diagnosed with malaria 23
Proportion of cases correctly medicated 22
**Significant difference at p<0.01.the mean for a given output, divided by the mean num-
ber of that output.
Results
The bottom of Table 1 shows the characteristics of the
facilities sampled. Only three of the facilities had labora-
tories; all three were CHAM facilities. Fifty-eight per
cent of facilities had inpatient beds, with 5.5 beds on
average in facilities with beds. Clinical staff employed at
a facility ranged from two people to twelve people, with
an average of 4.2 clinical staff present in a facility. Table 2
presents the total costs, outputs, and input variables,
and Table 3 describes the breakdown of costs by facility
type. The mean cost per patient, both inpatient and out-
patient, seen for all health facilities was US$ 7.16 (95%
CI: 5.24 to 9.08). CHAM facilities had an average cost of
US$ 10.36 (95% CI: 4.92 to 15.80) per patient seen, while
government facilities had an average cost of US$ 5.57
(95% CI: 4.52 to 6.60) per patient seen. Both total and
average costs show a wide range, with total costs per fa-
cility ranging from about $16,000 to almost $200,000
and average cost per patient ranging just under $2.50 to
over $10. When direct allocation is used to determine
average costs for inpatient and outpatient care, the aver-
age cost of an outpatient visit was $5.36 and $7.89 at
government and CHAM facilities, respectively, while an












(9,009) 192,174 (20,228) (9,467)
10,753 1,425 to 9,282 11,488 0.36
(1,103) 22,156 (2,605) (1,052)
133 0 to 117 140 0.86





5,205 2,194 to 6,540 4,536 0.06
(502) 13,374 (1,202) (390)
0.28 0.07 to 0.17 0.33 0.0003**
(0.02) 0.53 (0.02) (0.02)
0.54 0.05 to 0.48 0.57 0.38
(0.05) 0.91 (0.10) (0.05)
0 .85 0.66 to 0.80 0.87 0.12
(0.02) 0.97 (0.04) (0.02)
Table 3 Breakdown of costs by facility type
Item Facility type
Government health centres CHAM
Inputs (Children U5)
Variable
Staff remuneration 22% 39%
Training 9% 5%
Vehicle operation & Field visits 12% 11%
Non-medical supplies 1% 4%
Medical Supplies 6% 8%
Pharmaceuticals 38% 20%
Vaccines 2% 1%
Utilities & Maintenance 3% 2%
Lab & X-ray (variable) – 1%
Subtotal: Variable costs 93% 91%
Fixed




Subtotal: Fixed costs 7% 9%
Average costs calculated with direct allocation (US$)
Outpatient visit (sd) 5.36 7.89
(1.92) (4.39)
Inpatient admission (sd) 15.94 39.22
(7.60) (17.57)
sd = standard deviation.
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at CHAM facilities than at government facilities. Staff
remuneration and pharmaceuticals accounted for over
55% of total costs on average, and over 50% of costs at
all but three facilities. LA generally accounted for over
75% of pharmaceutical costs.
Donors directly financed 40% of costs at government
health centres, and 21% of costs at CHAM facilities, not
including funds provided through the SWAp. Pharma-
ceuticals and vaccines accounted for 78% of donor sup-
port at government health centres and 70% at CHAM
facilities. Donor procurement of LA was the most im-
portant component of this support.
Government and CHAM facilities had similar utilization
numbers, with an average of 10,753 child outpatient
visits (range among facilities: 1,425 to 22,156), over 100
inpatient admittances (range: 0 to 1,325), and about 900
fully immunized children (range: 0 to 2,342) with no
statistically significant differences between the two facil-
ity types.
On average, 27% of drugs used for children present at
facilities at some point during the fiscal year were out of
stock at the two time points measured (beginning orend of the fiscal year). This was 17% at CHAM facilities
and 33% at government health centres (p<0.01). An
average 54% of outpatient U5 cases were diagnosed with
malaria among the 26 facilities with this data. However,
malaria was diagnosed by observation and the propor-
tion of cases diagnosed with malaria ranges from 5% to
91% between facilities, calling into question the accuracy
of the diagnoses.
Regression analyses were done on total costs in natural
units, because the data in the raw scale had relatively
low skew and a kurtosis coefficient under 3 [21] (See
Additional file 2). Four regression specifications are
presented in Table 4. Proportion of drugs out of stock,
the proportion of cases diagnosed with malaria, average
salary of clinical staff, and the proportion of cases cor-
rectly medicated did not improve model fit in any of the
models (p<0.10) (data not shown). Outputs and the indi-
cator for CHAM facilities are only statistically significant
in the specification that includes the proportion of drugs
out of stock. The direction of the coefficient for the pro-
portion of drugs out of stock is positive. This finding is
difficult to interpret; perhaps having cheaper first line
drugs in stock lowers costs, or, because CHAM facilities
are more likely to have drugs in stock, this variable
could be capturing higher CHAM costs. The number of
fully immunized children does not improve model fit. All
other variables, including those assessing missingness, do
not improve model fit (p<0.10). The preferred specifica-
tion is Model 4, which had the highest R-squared and log
likelihood. We use this model for the remainder of the
analyses, although we report average and marginal cost
estimates for all models to facilitate comparisons. Results
appear to be robust based on sensitivity analyses (see
Additional file 1).
Table 5 presents the estimated marginal cost and aver-
age incremental cost of services. One more inpatient ad-
mission, for example in model 4, is associated with an
increase of $13.0 in total costs, which is also the average
incremental cost. For outpatient visits, the marginal cost
is estimated at under $1 in the fourth model. The
models show that marginal costs for outpatient visits are
lower than average incremental costs.
Figure 1 presents the estimated average incremental
cost and marginal cost curves, based on the fourth
model, for outpatient visits across the range of out-
patient visits observed. The mean number of outpatient
visits observed in the sample is close to the lowest mar-
ginal incremental cost, suggesting that average incre-
mental costs could be lowered if health facilities served
more children at the current level of quality.
In order to understand the cost profile at different
scales, in Table 6 we summarize the proportion of total
costs by cost category for three levels of outpatient
utilization: low utilization under 7,000 outpatient visits,
Table 4 Results of regression
Variable Beta coefficients (standard error)
Preferred
Model 1 Model 2 Model 3 Model 4
Outpatient visits 16.5 (10.2) 13.0 (10.5) 16.6 (10.5) 22.6 (8.5)*
Square of outpatient visits −0.001 −0.001 −0.01 (0.001) −0.002
(0.001) (0.001) (0.001)*
Cube of outpatient visits 4.0 × 10-8 4.0 × 10-8 4.0 × 10-8 7.0 × 10-8
(3.0 × 10-8) (3.0 × 10-8) (3.0 × 10-8) (2.0 × 10-8)*
Inpatient admissions 23.7 (21.4) 26.9 (21.3) 17.2 (66.2) 13.0 (17.6)
Square of inpatient admissions 0.006 (0.05)
Fully immunized children 16.2 (13.1)
CHAM facility 18,548 19,294 18,978 46,425
(14,283) (14,088) (15,263) (14,374)**
Proportion of drugs out of stock 1,862 (573)**
Constant −19,425 −20,249 −19,328 −87,976
(35,242) (34,737) (36,264) (35,425)*
N (Facilities) 24 24 24 24
Adjusted r-squared 0.625 0.636 0.603 0.755
Log likelihood −275.5 −274.4 −275.4 −269.7
Likelihood ratio test: p > chi2 compared to model 1 N/A 0.150 0.902 0.0007**
Dependent variable = Total facility cost of child health services for fiscal year 2009/2010 in US dollars (natural units).
*significant at p<0.05.
**significant at p<0.01.
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utilization of 15,000 visits and over.
Discussion
We find that an average health centre in the four se-
lected districts in Malawi is not operating at an optimalTable 5 Elasticity, per visit costs, and economies of scale
at government health centres and CHAM facilities at
mean values
Model Outpatient visits Inpatient admissions
E MC AIC E MC AIC
Government health centres
1 0.53 2.81 6.68 0.05 23.7
2 0.49 2.60 5.41 0.06 26.9
3 0.53 2.79 6.68 0.04 18.8 18.0
4 0.16 0.82 7.20 0.03 13.0
CHAM Facilities
1 0.34 2.66 7.64 0.04 23.7
2 0.30 2.37 6.12 0.04 26.9
3 0.34 2.64 7.65 0.03 18.5 17.9
4 0.10 0.79 8.76 0.02 13.0
E = Elasticity.
MC = Marginal incremental cost.
AIC = average incremental cost.scale of services. Table 6 shows that high utilization fa-
cilities spent 20% of their total budget, on average, for
vehicle operation and field visits. On the other hand,
staff and clinical staff at these facilities see more children
than at other facilities, and have the highest number of
visits per child in their catchment area per year. Because
high-utilization facilities are more likely to have vehicles
than other facilities, the upward slope of marginal costs
at high utilization levels indicated by the regression
probably reflects the cost of vehicle operation rather
than diseconomies of scale with respect to staff or other
fixed costs. Thus, the increasing average costs for facil-
ities over 15,000 visits should be interpreted with cau-
tion, and our models should include another output for
outputs related to vehicle use.
Facilities with low levels of utilization also tend to have
both a smaller population of children in their catchment
area and a lower number of visits per child per year.
Thus, these facilities have lower number of visits per
staff and per clinical staff, but these facilities also have a
greater number of non-clinical staff than facilities with
mid-levels of utilization. We also find, based on exit in-
terviews, that a greater proportion of caretakers reported
traveling over 1 hour to receive care among low-
utilization facilities compared with high utilization facil-
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Figure 1 Estimated average incremental cost and marginal cost for outpatient visits*. aic = average incremental cost mc = marginal
incremental cost vertical line = average number of outpatient visits in the observed sample. *This graph is constructed holding all variables at
their mean across facilities except for the number of child outpatient visits. We then predict the expected aic and mc for the outpatient volume
observed at all facilities in our sample. The presented lines connect these predicted values.
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These findings may be confounded by the fact that 4 of
the 6 low utilization facilities are CHAM health centres,
and user fees may lower demand. However, for the two
government-operated low utilization facilities, the aver-
age utilization rate is only 1.89 visits per child per year.
Thus, we cannot draw conclusions as to the reasons for
low utilization, but note that it appears to be associated
with lower levels of efficiency.
Likely, active steps are needed to increase demand and
utilization at these health centres; facilities with low
utilization (e.g., under 7,000 children in the catchment
area or with utilization rates under 2 visits per child per
year) would especially benefit from these activities. In-
creasing utilization rates would not fully help low
utilization facilities alleviate their inefficiency with re-
spect to scale since they serve a smaller number of
children; these facilities also appear most likely to be af-
fected by community-based case management since they
are possibly in more remote areas. The government,
which has goal of having the 80% of the population live
within 5 kilometres of a health facility [20], may be
willing to bear this loss of efficiency, but expansion of
non-child services is another possible way to alleviate
inefficiency. Staffing patterns may bear scrutiny; how-
ever, there may be reasons health facilities with smaller
catchment populations to have more non-clinical staff;
e.g., non-clinical staff may be used for outreach.
While CHAM facilities charge clients user fees, we
find, on average, their volume of visits is similar to
government health centres. Government health centresreceived, on average, 2.5 visits per child in their catch-
ment area in the year observed, while CHAM facilities
received 2.2 visits per child per year. We found, how-
ever, that 72% of all outpatient visits at CHAM facilities
were from children, compared with 36% at government
health centres. This helps explain why, despite similar
levels of outputs, CHAM facilities are more expensive;
their fixed and semi-fixed costs are, overall, spread
across fewer visits.
Our data do not measure quality well, but we found
that around 85% of children were prescribed a medicine
that was consistent with their recorded diagnosis. In an
observation-based study conducted in 2009, researchers
found that 53.6% of children with pneumonia, 63.4% of
children with malaria, and 43% of children with dehy-
dration were given the correct prescription [22]. These
rates, which were accompanied by confirmation of diag-
nosis, are substantially lower than in our data. Thus,
there may substantial room to improve the quality of
care, which is a second path to increasing the efficiency
of services. We also found a large proportion of drugs
were out of stock at government health centres, and that
higher stock-out rates were associated with higher costs.
This is another area where quality improvement may
improve cost profiles.
This study suffers from a number of weaknesses. Al-
though 1104 patient records were analysed the sample
size of facilities is only 24, and deriving conclusions from
small sample sizes is problematic. For example, based on
parameter uncertainty in the fourth model, the optimal
scale of services could as low as 5000 outpatient visits
Table 6 Breakdown of costs by facility utilization
Item Facility utilization level
Low utilization (Fewer than
7,000 outpatient visits)




Number of health centres 6 13 5
of which CHAM 4 2 2
Population served (average) 18,345 24,372 36,071
Estimated Children U5 (average) 3,385 4,597 6,561
Outputs (Children U5)
Inpatient admissions (average) 71 82 338
Outpatient visits (average) 4,446 10,507 18,961
FIC (average) 495 1,013 1,165
Child outpatient utilization rate 1.31 2.29 2.89
Proportion of caretakers reporting over 1 hour
travel time to facility (95% CI)*
67% 60% 56%
(52 – 81%) (47 – 73%) (41 – 71%)
Inputs (Children U5)
Variable
Staff remuneration 47% 23% 29%
Average number of clinical staff 3.7 3.8 5.8
Outpatient visits per clinical staff 1213 2732 3269
Average number of staff (all) 37.2 29.8 45.6
Outpatient visits per staff (all) 120 352 416
Training 5% 8% 6%
Vehicle operation & Field visits 6% 7% 20%
Non-medical supplies 1% 2% 3%
Medical Supplies 8% 7% 5%
Pharmaceuticals 18% 42% 22%
Average pharmaceutical spending per visit ($) 1.4 2.6 1.3
Proportion of drugs out of stock 0.19 0.32 0.28
Proportion of children correctly medicated 0.59 0.82 0.81
Subtotal: Variable costs 87% 94% 92%
Fixed
Building & Equipment (incl. lab/x-ray) 8% 5% 5%
Vehicles 5% 1% 3%
Subtotal: Fixed costs 13% 6% 8%
*Based on 229 exit interviews of caretakers at facilities; 60 respondents for low utilization facilities, 128 respondents for middle utilization facilities, and 41
respondents for high utilization facilities. Difference between low utilization and high utilization facilities is statistically significant (p<0.05) in logit regression when
controlling for district (data not shown).
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visits observed at any health centre (data not shown), and
deriving benchmark figures for optimal utilization requires
more study. Further, our survey only covered four of
Malawi’s 28 districts, making it difficult to generalize
about all of Malawi. (In Additional file 3 we provide a
comparison of basic indicators for the 4 districts selected
and for Malawi as a whole showing that the 4 districts
were actually quite representative in their health statistics).
Further, the quality of the data was not always optimal.Often, confirmation of data, e.g., in registries, found dis-
crepancies with officially reported data. In some cases, re-
cords were missing or incomplete. However, the results
appear robust to moderate levels of data error (see
Additional file 3).
Assessing how costs change over time, and how they
change in relation to new programmes, is important
both to provide feedback to facility and district managers
and to inform projections of the amount of resources
needed to achieve health and mortality reduction goals.
Johns et al. Cost Effectiveness and Resource Allocation 2013, 11:10 Page 9 of 9
http://www.resource-allocation.com/content/11/1/10We plan to conduct a follow-up study at the same facil-
ities after the community-based case management pro-
gram has matured.
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